Ashley Holder
Co-Principal Investigator and Program Director · University of Texas M D Anderson Cancer Center
Credentials: · · · · · · ·
History
- Present
Co-Principal Investigator and · University of Texas M D Anderson Cancer Center
- 2004–2008
Research
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 336 citations
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Journal of the National Comprehensive Cancer Network · 2021 · 269 citations
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Review · Nature reviews. Cancer · 2024 · First of 7 authors · 258 citations
6 papers
5 papers
4 papers
4 papers · 2 as a fellow
4 papers · 1 as a fellow
3 papers · 3 as a fellow
3 papers · 2 as a fellow
3 papers
Grants
- 2026–2028
Optimizing TIL Harvest Site and Patient Selection with CD8-PET Imaging
National Cancer Institute · R21
Contact PI · $421.7K · University of Tx Md Anderson Can Ctr
- 2024–2028
Targeting the Gut Microbiome to Inhibit Melanoma Lymph Node Metastases
National Cancer Institute · R01
PI · $1.6M · University of Tx Md Anderson Can Ctr
- 1994–2028
Training of Academic Surgical Oncologists
National Cancer Institute · T32
PI · $2M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2027–2030
Principal investigator · Not yet recruiting
M.D. Anderson Cancer Center